EUR43.5 million, up +42.2% BILENDI BILENDI: Revenue for the first half of 2025: EUR43.5 million, up +42.2% 23-Jul-2025 / 17:37 CET/CEST Dissemination ...

DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology Approval represents critical advancement in early intervention for multiple myeloma ...

FFB Bancorp (the "Company") (OTCQX: FFBB), the parent company of FFB Bank (the "Bank"), today reported net income of $6.04 million, or $1.94 per diluted ...

Highlights for Second Quarter of 2025 Net income of $5.186 million during the second quarter of 2025, an increase ...

Hudson Global, Inc. (the "Company" or "Hudson RPO") (Nasdaq: HSON), a leading global total talent solutions company, announced today the acquisition ...

Stargaze Entertainment Group Inc. ("Stargaze" or the "Company") (OTCQB: STGZ), a next-generation content creation and social platform designed to redefine ...

Revenues for H1 2025: €1,761.7m, +16.0% (+17.1% at constant exchange rates) Commercial momentum remains strong ...